Apeiron Investment Group Ltd.
SEC CIK 1845711 · EDGAR
BoughtSold
Most active insiders at ENHA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Apeiron Investment Group Ltd. | Dir, 10% | $11.05M | — |
| 2 | Martin Maximilian | CEO, Dir | — | — |
| 3 | ASPAC IV (Holdings) Corp. | 10% | — | — |
| 4 | MURREN JAMES | Dir | — | — |
Transactions 12
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-09-21 21:30 | 2026-09-17 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.15 | +6.08M | 43.34M | +16% | +$6.99M |
| MI | 2026-09-09 19:08 | 2026-09-04+ | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.59 | +179.7K | 37.26M | +0.5% | +$286.3K |
| MI | 2026-09-04 16:30 | 2026-09-02+ | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.58 | +133.1K | 37.08M | +0.4% | +$209.8K |
| DI | 2026-08-20 07:30 | 2026-08-14 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | A - Grant | — | +2.12M | 35.18M | +6% | — |
| DMI | 2026-08-20 07:30 | 2026-08-18+ | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.66 | +1.77M | 36.95M | +5% | +$2.94M |
| I | 2026-08-18 08:55 | 2026-08-17 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.65 | +200.0K | 33.06M | +0.6% | +$330.4K |
| I | 2026-08-17 06:10 | 2026-08-14 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | P - Purchase | $1.97 | +150.0K | 32.86M | +0.5% | +$295.6K |
| DI | 2026-07-24 18:30 | 2026-07-22 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | A - Grant | — | +3.02M | 32.71M | +10% | — |
| DMI | 2026-05-11 18:51 | 2026-05-07 | ENHA | Enhanced Group Inc. | Apeiron Investment Group Ltd. | Dir, 10% | A - Grant | — | +288.53M | 258.84M | New | — |
| DI | 2024-03-06 | 2024-02-06 | ANRO | Alto Neuroscience, Inc. | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +674.7K | 674.7K | New | — |
| D | 2024-03-06 | 2024-02-06 | ANRO | Alto Neuroscience, Inc. | Apeiron Investment Group Ltd. | See Remarks | C - Cnv Deriv | — | +251.9K | 251.9K | New | — |
| MI | 2023-02-27 | 2023-02-23 | FTH | Faeth Therapeutics, Inc. | Apeiron Investment Group Ltd. | 10% | P - Purchase | $1.61 | +2,200 | 2.49M | +0.1% | +$3,542 |